Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |